For: | Herzer K, Gerken G. Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents. World J Hepatol 2015; 7(3): 532-538 [PMID: 25848476 DOI: 10.4254/wjh.v7.i3.532] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i3/532.htm |
Number | Citing Articles |
1 |
Salvatore Monaco, Sara Mariotto, Sergio Ferrari, Massimiliano Calabrese, Gianluigi Zanusso, Alberto Gajofatto, Domenico Sansonno, Franco Dammacco. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World Journal of Gastroenterology 2015; 21(42): 11974-11983 doi: 10.3748/wjg.v21.i42.11974
|
2 |
Jacqueline G. O'Leary, Robert J. Fontana, Kimberly Brown, James R. Burton, Roberto Firpi-Morell, Andrew Muir, Christopher O'Brien, Mordechai Rabinovitz, Rajender Reddy, Robert Ryan, Adam Shprecher, Shirley Villadiego, Avinash Prabhakar, Robert S. Brown. Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study. Transplant International 2017; 30(2): 196 doi: 10.1111/tri.12896
|
3 |
Fungai Dengu, Syed Hussain Abbas, Georg Ebeling, David Nasralla. Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review. Journal of Clinical Medicine 2020; 9(4): 1046 doi: 10.3390/jcm9041046
|
4 |
M. Jahn, K. Herzer, O. Witzke. Hepatitis C und Nierenerkrankungen. Der Nephrologe 2016; 11(5): 361 doi: 10.1007/s11560-016-0091-0
|